ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/23 | 1,620 | 1,647 | 1,601 | 1,612 | +1 | +0.1% | 130,200 |
2021/03/22 | 1,640 | 1,643 | 1,592 | 1,611 | -35 | -2.1% | 191,700 |
2021/03/19 | 1,653 | 1,663 | 1,640 | 1,646 | -41 | -2.4% | 113,000 |
2021/03/18 | 1,650 | 1,718 | 1,650 | 1,687 | +25 | +1.5% | 193,300 |
2021/03/17 | 1,622 | 1,665 | 1,622 | 1,662 | +15 | +0.9% | 183,100 |
2021/03/16 | 1,585 | 1,654 | 1,573 | 1,647 | +40 | +2.5% | 171,400 |
2021/03/15 | 1,630 | 1,635 | 1,586 | 1,607 | ±0 | ±0% | 126,300 |
2021/03/12 | 1,572 | 1,617 | 1,560 | 1,607 | +40 | +2.6% | 189,900 |
2021/03/11 | 1,540 | 1,568 | 1,525 | 1,567 | +16 | +1% | 187,100 |
2021/03/10 | 1,578 | 1,578 | 1,535 | 1,551 | ±0 | ±0% | 371,200 |
2021/03/09 | 1,585 | 1,585 | 1,510 | 1,551 | -22 | -1.4% | 261,800 |
2021/03/08 | 1,605 | 1,613 | 1,571 | 1,573 | -11 | -0.7% | 135,000 |
2021/03/05 | 1,616 | 1,616 | 1,545 | 1,584 | -60 | -3.6% | 269,500 |
2021/03/04 | 1,640 | 1,644 | 1,590 | 1,644 | +4 | +0.2% | 141,300 |
2021/03/03 | 1,661 | 1,667 | 1,605 | 1,640 | -27 | -1.6% | 217,300 |
2021/03/02 | 1,705 | 1,723 | 1,666 | 1,667 | -40 | -2.3% | 132,000 |
2021/03/01 | 1,734 | 1,749 | 1,664 | 1,707 | -27 | -1.6% | 149,500 |
2021/02/26 | 1,735 | 1,773 | 1,711 | 1,734 | -35 | -2% | 157,300 |
2021/02/25 | 1,760 | 1,815 | 1,717 | 1,769 | +39 | +2.3% | 167,700 |
2021/02/24 | 1,792 | 1,793 | 1,728 | 1,730 | -62 | -3.5% | 260,600 |
2021/02/22 | 1,820 | 1,821 | 1,766 | 1,792 | -15 | -0.8% | 231,300 |
2021/02/19 | 1,780 | 1,835 | 1,772 | 1,807 | +12 | +0.7% | 278,900 |
2021/02/18 | 1,706 | 1,800 | 1,706 | 1,795 | +89 | +5.2% | 309,900 |
2021/02/17 | 1,732 | 1,757 | 1,694 | 1,706 | +10 | +0.6% | 287,400 |
2021/02/16 | 1,637 | 1,698 | 1,576 | 1,696 | +134 | +8.6% | 292,900 |
2021/02/15 | 1,631 | 1,631 | 1,561 | 1,562 | -83 | -5% | 325,600 |
2021/02/12 | 1,678 | 1,680 | 1,631 | 1,645 | -41 | -2.4% | 93,700 |
2021/02/10 | 1,670 | 1,703 | 1,670 | 1,686 | -2 | -0.1% | 69,900 |
2021/02/09 | 1,684 | 1,693 | 1,655 | 1,688 | +20 | +1.2% | 114,000 |
2021/02/08 | 1,703 | 1,757 | 1,661 | 1,668 | -14 | -0.8% | 226,600 |
2021/02/05 | 1,660 | 1,695 | 1,657 | 1,682 | +39 | +2.4% | 64,900 |
2021/02/04 | 1,670 | 1,675 | 1,634 | 1,643 | -28 | -1.7% | 95,200 |
2021/02/03 | 1,678 | 1,708 | 1,663 | 1,671 | -9 | -0.5% | 99,800 |
2021/02/02 | 1,642 | 1,692 | 1,620 | 1,680 | +63 | +3.9% | 91,600 |
2021/02/01 | 1,600 | 1,628 | 1,582 | 1,617 | +14 | +0.9% | 93,700 |
2021/01/29 | 1,630 | 1,652 | 1,602 | 1,603 | -35 | -2.1% | 90,700 |
2021/01/28 | 1,626 | 1,645 | 1,609 | 1,638 | -27 | -1.6% | 155,200 |
2021/01/27 | 1,632 | 1,685 | 1,627 | 1,665 | +13 | +0.8% | 122,000 |
2021/01/26 | 1,710 | 1,710 | 1,646 | 1,652 | -62 | -3.6% | 156,100 |
2021/01/25 | 1,654 | 1,714 | 1,652 | 1,714 | +58 | +3.5% | 166,100 |
2021/01/22 | 1,637 | 1,661 | 1,614 | 1,656 | +9 | +0.5% | 277,600 |
2021/01/21 | 1,665 | 1,668 | 1,638 | 1,647 | -22 | -1.3% | 182,900 |
2021/01/20 | 1,699 | 1,703 | 1,638 | 1,669 | -7 | -0.4% | 262,200 |
2021/01/19 | 1,733 | 1,733 | 1,676 | 1,676 | -22 | -1.3% | 154,600 |
2021/01/18 | 1,719 | 1,746 | 1,676 | 1,698 | -26 | -1.5% | 191,500 |
2021/01/15 | 1,791 | 1,800 | 1,723 | 1,724 | -67 | -3.7% | 277,400 |
2021/01/14 | 1,800 | 1,821 | 1,783 | 1,791 | +4 | +0.2% | 161,000 |
2021/01/13 | 1,790 | 1,801 | 1,771 | 1,787 | -13 | -0.7% | 84,100 |
2021/01/12 | 1,823 | 1,827 | 1,786 | 1,800 | -33 | -1.8% | 209,900 |
2021/01/08 | 1,849 | 1,850 | 1,808 | 1,833 | -13 | -0.7% | 156,500 |
901~
950
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム